Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZW) Equity Ratio (2020 - 2025)

Core Scientific (CORZW) has disclosed Equity Ratio for 6 consecutive years, with 0.41 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 35.82% to 0.41 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.41 through Dec 2025, up 35.82% year-over-year, with the annual reading at 0.41 for FY2025, 35.82% up from the prior year.
  • Equity Ratio hit 0.41 in Q4 2025 for Core Scientific, up from 0.58 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.55 in Q4 2021 to a low of 1.78 in Q2 2024.
  • Historically, Equity Ratio has averaged 0.35 across 5 years, with a median of 0.46 in 2022.
  • Biggest five-year swings in Equity Ratio: surged 135.38% in 2022 and later crashed 1241.14% in 2023.
  • Year by year, Equity Ratio stood at 0.55 in 2021, then plummeted by 192.16% to 0.51 in 2022, then tumbled by 65.39% to 0.84 in 2023, then grew by 23.77% to 0.64 in 2024, then surged by 35.82% to 0.41 in 2025.
  • Business Quant data shows Equity Ratio for CORZW at 0.41 in Q4 2025, 0.58 in Q3 2025, and 0.64 in Q2 2025.